URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kishan Pandya

Concepts (262)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
19
1982
436
2.630
Why?
Breast Neoplasms
20
1980
666
2.170
Why?
Lung Neoplasms
12
1986
435
1.690
Why?
Hot Flashes
4
2000
25
1.540
Why?
Carcinoma, Non-Small-Cell Lung
7
2000
70
1.390
Why?
Cyclohexanecarboxylic Acids
3
2004
46
1.140
Why?
Amines
3
2004
63
1.140
Why?
gamma-Aminobutyric Acid
3
2004
97
1.110
Why?
Tamoxifen
7
1994
84
1.030
Why?
Taxoids
2
2009
13
0.890
Why?
Neoplasms
9
1988
743
0.880
Why?
Neoplasm Metastasis
15
1980
229
0.850
Why?
Colonic Neoplasms
4
1986
123
0.830
Why?
Antineoplastic Agents
8
1982
628
0.790
Why?
Pain
4
1993
392
0.730
Why?
Analgesics
3
1993
116
0.700
Why?
Carboplatin
1
2009
29
0.700
Why?
Fluorouracil
10
1986
78
0.680
Why?
Middle Aged
42
1980
10013
0.680
Why?
Diphosphonates
1
2009
41
0.680
Why?
Imidazoles
1
2009
67
0.680
Why?
Carcinoma, Small Cell
1
2007
33
0.630
Why?
Sirolimus
1
2007
30
0.620
Why?
Aged
34
1982
7392
0.600
Why?
Neoplasm Recurrence, Local
8
1980
295
0.600
Why?
Female
47
1980
20222
0.590
Why?
Protein Kinase Inhibitors
1
2007
97
0.580
Why?
Radiation-Sensitizing Agents
4
2001
74
0.550
Why?
Menopause
2
1993
38
0.540
Why?
Paclitaxel
4
2001
59
0.520
Why?
Aged, 80 and over
13
1993
2588
0.520
Why?
Cisplatin
8
1986
93
0.510
Why?
Antineoplastic Agents, Phytogenic
4
2000
37
0.500
Why?
Humans
57
1980
37165
0.490
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.490
Why?
Acetates
1
2004
65
0.470
Why?
Adult
32
1982
11572
0.450
Why?
Treatment Outcome
12
1993
2671
0.450
Why?
Drug Administration Schedule
7
1998
374
0.390
Why?
Endometrial Neoplasms
1
2001
38
0.380
Why?
Clonidine
1
2000
34
0.370
Why?
Adrenergic alpha-Agonists
1
2000
37
0.370
Why?
Neoplasm Staging
4
2007
354
0.370
Why?
Postmenopause
1
2000
42
0.370
Why?
Antineoplastic Agents, Hormonal
1
2000
44
0.360
Why?
Drug Prescriptions
2
1993
43
0.360
Why?
Male
28
1980
20139
0.360
Why?
Rectal Neoplasms
3
1986
84
0.360
Why?
Etoposide
4
1995
83
0.360
Why?
Remission Induction
8
1989
165
0.330
Why?
Appetite Stimulants
1
1998
1
0.330
Why?
Megestrol Acetate
1
1998
1
0.330
Why?
Survival Rate
6
1998
619
0.320
Why?
Carcinoma, Renal Cell
1
1998
56
0.310
Why?
Minority Groups
1
1997
59
0.310
Why?
Interferon-alpha
1
1998
85
0.310
Why?
Kidney Neoplasms
1
1998
104
0.300
Why?
Ambulatory Care
2
1994
167
0.290
Why?
Pilot Projects
7
1985
446
0.290
Why?
Follow-Up Studies
8
1992
1889
0.280
Why?
Chemotherapy, Adjuvant
2
1994
88
0.270
Why?
Amenorrhea
1
1994
20
0.260
Why?
Double-Blind Method
4
2000
996
0.250
Why?
Cyclophosphamide
5
1982
177
0.230
Why?
Nausea
3
1980
155
0.230
Why?
Administration, Oral
3
2000
314
0.220
Why?
Combined Modality Therapy
5
1985
491
0.220
Why?
Vomiting
2
1992
116
0.220
Why?
Doxorubicin
5
1995
105
0.220
Why?
Palliative Care
2
1989
161
0.220
Why?
Proportional Hazards Models
3
2000
426
0.220
Why?
Research Design
2
1988
340
0.210
Why?
Vincristine
4
1982
61
0.200
Why?
Pain Measurement
2
1994
248
0.200
Why?
Survival Analysis
7
1993
589
0.200
Why?
Disease-Free Survival
3
1994
204
0.200
Why?
Canada
2
1994
77
0.190
Why?
Vitis
1
2010
5
0.190
Why?
Physician's Practice Patterns
1
1993
268
0.180
Why?
Hospitals, Community
1
1990
72
0.180
Why?
Beverages
1
2010
33
0.180
Why?
Adenocarcinoma
4
1995
483
0.180
Why?
Mitomycin
4
1986
18
0.180
Why?
Questionnaires
4
1993
1061
0.170
Why?
Spiro Compounds
1
1988
5
0.170
Why?
Time Factors
6
1980
3234
0.170
Why?
Fibroblast Growth Factor 7
1
2008
11
0.160
Why?
Pneumonectomy
1
2008
14
0.160
Why?
Organometallic Compounds
1
1988
70
0.160
Why?
Antidepressive Agents
1
2009
93
0.160
Why?
Camptothecin
1
2007
8
0.160
Why?
Liver Neoplasms
4
1980
155
0.160
Why?
Health Status Indicators
1
2008
112
0.160
Why?
Head and Neck Neoplasms
1
2008
84
0.150
Why?
United States
4
1988
2847
0.150
Why?
Drug Evaluation
8
1980
99
0.150
Why?
Drug Therapy, Combination
4
1982
397
0.150
Why?
Treatment Failure
1
2007
131
0.150
Why?
Infusions, Intravenous
4
1989
143
0.140
Why?
Neoplasms, Second Primary
1
2008
125
0.140
Why?
Carcinoma, Squamous Cell
1
2008
238
0.140
Why?
Placebos
2
2000
185
0.130
Why?
Patient Selection
1
2007
223
0.130
Why?
Vinblastine
2
1986
27
0.130
Why?
Procarbazine
1
2004
12
0.120
Why?
Disease Progression
2
2000
533
0.120
Why?
Severity of Illness Index
2
2004
943
0.120
Why?
Antimetabolites, Antineoplastic
2
1998
40
0.110
Why?
Thoracic Neoplasms
1
2003
20
0.110
Why?
Dysgerminoma
1
1982
8
0.110
Why?
Medical Oncology
2
1992
49
0.110
Why?
Mediastinal Neoplasms
1
1982
21
0.110
Why?
Prognosis
4
1985
1078
0.110
Why?
Recombinant Proteins
2
1998
770
0.100
Why?
Lymphatic Metastasis
3
1994
153
0.100
Why?
Megestrol
1
2001
3
0.100
Why?
Oncologic Nursing
2
1992
9
0.100
Why?
Professional Staff Committees
1
2001
7
0.100
Why?
Radiation Oncology
1
2001
18
0.100
Why?
Hyperaldosteronism
1
1980
6
0.100
Why?
Patient Dropouts
1
2000
29
0.090
Why?
Thioguanine
1
1980
15
0.090
Why?
Quality-Adjusted Life Years
1
2000
53
0.090
Why?
Immunotherapy, Active
1
1999
5
0.090
Why?
Methotrexate
4
1982
73
0.090
Why?
Cancer Vaccines
1
1999
32
0.090
Why?
Age Factors
2
1990
1152
0.080
Why?
Mitomycins
3
1986
17
0.080
Why?
Interleukin-1
1
1999
221
0.080
Why?
Tomography, X-Ray Computed
3
1982
785
0.070
Why?
Dose-Response Relationship, Radiation
2
2003
216
0.070
Why?
Prospective Studies
2
1993
1696
0.070
Why?
Menopause, Premature
1
1994
2
0.070
Why?
Stomach Neoplasms
1
1995
40
0.060
Why?
Menstruation
1
1994
16
0.060
Why?
Premenopause
1
1994
13
0.060
Why?
Ovariectomy
1
1994
45
0.060
Why?
Randomized Controlled Trials as Topic
2
1992
415
0.060
Why?
Ovary
1
1994
89
0.060
Why?
Multicenter Studies as Topic
1
1994
127
0.060
Why?
Fluoxymesterone
3
1997
4
0.060
Why?
Drug Utilization
1
1994
47
0.060
Why?
Goserelin
1
1993
7
0.060
Why?
Occult Blood
1
1993
9
0.060
Why?
Prostatic Neoplasms
2
1989
540
0.060
Why?
Health Services Needs and Demand
1
1994
114
0.060
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Analgesics, Opioid
1
1993
99
0.050
Why?
Drug Therapy
1
1992
48
0.050
Why?
Recurrence
2
1997
697
0.050
Why?
Regression Analysis
1
1993
539
0.050
Why?
Education, Medical
1
1993
140
0.050
Why?
Mitosis
2
2000
101
0.050
Why?
Colorectal Neoplasms
1
1993
143
0.050
Why?
Drugs, Investigational
1
1990
8
0.050
Why?
Indazoles
1
1990
6
0.050
Why?
Tumor Stem Cell Assay
1
2010
24
0.050
Why?
Quality of Life
2
1998
528
0.050
Why?
Behavior Therapy
1
1992
110
0.050
Why?
Cell Cycle
2
2001
253
0.050
Why?
Dose Fractionation
1
2010
57
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2010
45
0.050
Why?
Translational Medical Research
1
2010
38
0.050
Why?
Bias (Epidemiology)
1
1990
43
0.050
Why?
Eating
1
2010
86
0.050
Why?
Retrospective Studies
2
1985
2302
0.050
Why?
Aminoglutethimide
1
1989
6
0.050
Why?
Health Knowledge, Attitudes, Practice
1
1993
296
0.040
Why?
Tumor Cells, Cultured
2
2001
886
0.040
Why?
Flavonoids
1
2010
70
0.040
Why?
Sensitivity and Specificity
2
1993
914
0.040
Why?
Hydrocortisone
1
1989
133
0.040
Why?
Psychometrics
1
2010
232
0.040
Why?
Abdominal Neoplasms
1
2008
17
0.040
Why?
Mucositis
1
2008
14
0.040
Why?
Carcinoid Tumor
1
2008
27
0.040
Why?
Glutamates
1
2008
38
0.040
Why?
Adenoma
1
2008
56
0.040
Why?
Pituitary Neoplasms
1
2008
66
0.040
Why?
Self-Assessment
1
2008
51
0.040
Why?
Deoxycytidine
1
2008
28
0.040
Why?
Guanine
1
2008
50
0.040
Why?
Cell Line, Tumor
1
2010
576
0.040
Why?
Carcinoma
1
1989
194
0.040
Why?
Oxazoles
1
1986
9
0.040
Why?
Isoxazoles
1
1986
16
0.040
Why?
Clinical Trials as Topic
2
1986
685
0.040
Why?
9,10-Dimethyl-1,2-benzanthracene
1
1986
36
0.040
Why?
Antibiotics, Antineoplastic
1
1986
49
0.040
Why?
Cytosine
1
1986
32
0.040
Why?
Anthracenes
1
1985
5
0.030
Why?
Chronic Disease
1
2008
554
0.030
Why?
Leukopenia
1
1985
26
0.030
Why?
Physicians
1
1988
161
0.030
Why?
Risk Factors
2
1993
2331
0.030
Why?
Anthraquinones
1
1984
6
0.030
Why?
Hematologic Diseases
2
1986
40
0.030
Why?
New York
1
1990
1378
0.030
Why?
Reproducibility of Results
1
2008
903
0.030
Why?
Glucocorticoids
1
1986
168
0.030
Why?
Dose-Response Relationship, Drug
1
2008
1142
0.030
Why?
Mammary Neoplasms, Experimental
1
1986
239
0.030
Why?
Lung Diseases
1
1986
224
0.030
Why?
Risk Assessment
1
2008
875
0.030
Why?
Young Adult
1
2008
1084
0.030
Why?
Maximum Tolerated Dose
1
2003
18
0.030
Why?
G2 Phase
1
2003
29
0.030
Why?
Leucovorin
1
1982
12
0.030
Why?
Iodipamide
1
1982
9
0.030
Why?
Diatrizoate
1
1982
18
0.030
Why?
Diatrizoate Meglumine
1
1982
17
0.030
Why?
Prednisone
2
1986
182
0.030
Why?
Cytarabine
1
1982
93
0.030
Why?
Burkitt Lymphoma
1
1982
53
0.030
Why?
Mesothelioma
1
2001
28
0.030
Why?
Radiotherapy Dosage
1
2001
202
0.020
Why?
Organizational Objectives
1
2001
27
0.020
Why?
Spironolactone
1
1980
12
0.020
Why?
Ascites
1
1980
20
0.020
Why?
Aldosterone
1
1980
21
0.020
Why?
Diarrhea
1
2000
65
0.020
Why?
Axilla
1
2000
20
0.020
Why?
Likelihood Functions
1
2000
54
0.020
Why?
Serum Albumin
1
1980
97
0.020
Why?
Alkaline Phosphatase
1
1980
153
0.020
Why?
Blood Cell Count
1
1980
45
0.020
Why?
Interprofessional Relations
1
2001
78
0.020
Why?
Forecasting
1
2001
188
0.020
Why?
Hodgkin Disease
1
1982
156
0.020
Why?
Bilirubin
1
1980
74
0.020
Why?
Edema
1
1980
116
0.020
Why?
Cause of Death
1
2000
158
0.020
Why?
Hepatitis B Antibodies
1
1999
11
0.020
Why?
Europe
1
1999
77
0.020
Why?
Lipid A
1
1999
10
0.020
Why?
Mycobacterium
1
1999
8
0.020
Why?
Skin Tests
1
1999
34
0.020
Why?
Receptors, Estrogen
2
1984
180
0.020
Why?
Adolescent
1
2008
5044
0.020
Why?
Mitolactol
1
1998
6
0.020
Why?
Adjuvants, Immunologic
1
1999
118
0.020
Why?
Flow Cytometry
1
2000
603
0.020
Why?
Mastectomy
1
1997
42
0.020
Why?
Apoptosis
1
2003
855
0.020
Why?
Cohort Studies
1
2000
984
0.020
Why?
Bone Neoplasms
1
1998
208
0.020
Why?
Follicle Stimulating Hormone
1
1993
52
0.010
Why?
Gonadal Steroid Hormones
1
1993
36
0.010
Why?
Reagent Kits, Diagnostic
1
1993
15
0.010
Why?
Attitude of Health Personnel
1
1994
302
0.010
Why?
Mass Screening
1
1993
270
0.010
Why?
Gastrointestinal Diseases
1
1986
35
0.010
Why?
Respiratory Function Tests
1
1986
129
0.010
Why?
Interferons
1
1986
47
0.010
Why?
Central Nervous System Diseases
1
1986
59
0.010
Why?
Organ Size
1
1986
194
0.010
Why?
Progesterone
1
1986
91
0.010
Why?
Rats, Inbred Strains
1
1986
654
0.010
Why?
Mitoxantrone
1
1984
20
0.010
Why?
Bone Marrow
1
1986
292
0.010
Why?
Rats
1
1986
4389
0.000
Why?
Animals
1
1986
16416
0.000
Why?

Visualizations


Pandya's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department